Profile
Turenne Capital is an independent investment firm based in France, specializing in small-cap companies. Founded in 1999, the firm has a team of over 90 professionals dispersed among eight regional offices. Their team includes experts in various sectors, committed to driving growth in their portfolio companies by leveraging local insights and strategic expertise. This regional reach and deep industry knowledge set them apart in the French investment landscape.
The firm invests across several sectors including Health, Energy and Environment, HoReCa/Hospitality, and Industrial sectors, targeting growth-stage companies. Typical investments range from Series A to later stages, with a check size inferred between $10-50 million. They manage assets worth approximately €2.2 billion, supporting over 300 companies in their portfolio.
Notable investments in Turenne Capital's portfolio include companies such as PathoQuest - a molecular diagnostics firm, Tampopo Group - a ramen chain, Kizeo - a workflow management software provider, and O2D Environnement - a solutions provider for sustainable urban and rural development. They emphasize regional growth and impact through strategic capital and management support.
Industry
Turenne Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Emergence Fund II
|
Venture Capital (VC)
|
Energy
CleanTech
ClimateTech
|
Seed
Series A
|
Europe
|
$5-10 m
|
$148 M
|
January 2025
|
|
Emergence Fund I
|
Venture Capital (VC)
|
Technology
Energy
CleanTech
ClimateTech
|
Seed
Series A
|
Europe
|
$5-10 m
|
$65 M
|
October 2016
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.